Q& M proposes to buy interest in dental group in Thailand
Purchase consideration will be satisfied by a combination of cash and new ordinary shares
 
[SINGAPORE] Q& M Dental Group is proposing to acquire equity interest in a dental group in Thailand, the company said in a bourse filing on Wednesday (Oct 15).
 
The group operates one of Thailand&rsquo s largest privately owned dental clinic networks, with more than 30 clinics across the country. 
 
These are located primarily in Bangkok and in major north-eastern provinces such as Udon Thani, Khon Kaen and Ubon Ratchathani.
 
Q& M said the target company&rsquo s network focuses on accessible, standardised, and patient-oriented dental care in high-traffic urban and suburban areas.
 
The purchase consideration will be satisfied by a combination of cash and new ordinary shares to be issued by Q& M, subject to a moratorium period. 
 
The purchase consideration is based on the target&rsquo s enterprise value of 1.95 billion baht (S$77.7 million) on a cash-free and debt-free basis, subject to customary net working capital adjustments to be made at completion.
 
Q& M said the acquisition supports its long-term strategic objectives by enabling a measured and strategic entry into Thailand&rsquo s private dental market through an established local operator.
 
Q& M said that by expanding beyond Singapore and Malaysia, it will &ldquo diversify its market exposure and reduce reliance on its existing core markets&rdquo .
 
Thailand&rsquo s private dental healthcare sector also presents significant growth potential, it added, driven by rising consumer awareness, increasing personal healthcare expenditure and growing demand for standardised dental treatments.
 
Q& M has entered into a non-binding memorandum of understanding on Wednesday for the proposed acquisition.
 
The vendors have guaranteed to achieve certain levels of net income from 2026 to 2030, and further profit targets of at least 285 million baht for the financial years 2031, 2032 and 2033, the company noted.
The dental group proposed to acquire an equity interest in a peer in Thailand, it said in a bourse filing on Wednesday. Q&M said the target company?s network focuses on accessible, standardised and patient-oriented dental care in high-traffic urban and suburban areas. The purchase consideration will be satisfied by a combination of cash and new ordinary shares to be issued by Q&M, and is based on the target?s enterprise value of about 1.95 billion baht (S$77.7 million) on a cash-free and debt-free basis. Shares of Q&M Dental closed 3.4 per cent or S$0.015 higher at S$0.455 on Wednesday, before the announcement.
Aoxin Q & M Dental Group Limited
Aoxin Q & M Dental Group Limited (?Aoxin Q & M?, together with its subsidiaries, the ?Group?) is a leading provider of private dental healthcare services in Liaoning Province, Northern PRC.
The Group currently operates 16 dental centres, comprising 9 dental polyclinics and 7 dental hospitals, located across 8 cities in Liaoning Province, namely, Shenyang, Huludao, Panjin, Gaizhou, Zhuanghe, Jinzhou, Anshan and Dalian. We currently have 401 dental professionals, including 146 dentists, 165 dental surgery assistants and 90 laboratory technicians. A majority of our dental centres are accredited as Designated Medical Institutions of Medical Insurance in PRC.
Additionally, the Group is engaged in the provision of dental laboratory services, as well as the distribution and sale of dental equipment and supplies in the Liaoning, Heilongjiang and Jilin Provinces in northern PRC.
Aoxin Q & M owns a 49% shareholding stake in Acumen Diagnostics Pte. Ltd. ("Acumen"). Acumen's business segments consist of (i) the laboratory business and (ii) offering COVID-19 vaccinations to the Singapore public pursuant to the tender contract with MOH at the Sengkang JTVC. As at the date of Annual Report 2024, Acumen is dormant subsequent to the cessation of its laboratory business on 15 September 2024 and the expiry of Sengkang JTVC contract on 1 December 2024.
Aoxin Q & M was listed on the Catalist board of the Singapore Exchange Securities Trading Limited on 26 April 2017.
Aoxin Q & M Dental Group Limited (?Aoxin Q & M?, together with its subsidiaries, the ?Group?) is a leading provider of private dental healthcare services in Liaoning Province, Northern PRC.
The Group currently operates 16 dental centres, comprising 9 dental polyclinics and 7 dental hospitals, located across 8 cities in Liaoning Province, namely, Shenyang, Huludao, Panjin, Gaizhou, Zhuanghe, Jinzhou, Anshan and Dalian. We currently have 401 dental professionals, including 146 dentists, 165 dental surgery assistants and 90 laboratory technicians. A majority of our dental centres are accredited as Designated Medical Institutions of Medical Insurance in PRC.
Additionally, the Group is engaged in the provision of dental laboratory services, as well as the distribution and sale of dental equipment and supplies in the Liaoning, Heilongjiang and Jilin Provinces in northern PRC.
Aoxin Q & M owns a 49% shareholding stake in Acumen Diagnostics Pte. Ltd. ("Acumen"). Acumen's business segments consist of (i) the laboratory business and (ii) offering COVID-19 vaccinations to the Singapore public pursuant to the tender contract with MOH at the Sengkang JTVC. As at the date of Annual Report 2024, Acumen is dormant subsequent to the cessation of its laboratory business on 15 September 2024 and the expiry of Sengkang JTVC contract on 1 December 2024.
Aoxin Q & M was listed on the Catalist board of the Singapore Exchange Securities Trading Limited on 26 April 2017.
11:27 PM EDT, 10/12/2025 (MT Newswires) -- Q & M Dental (SGX:QC7) gave an irrevocable undertaking to subscribe for a pro rata entitlement of 269.3 million rights shares for around SG$8.1 million and 242.2 million shares in excess of provisional allotments for SG$7.3 million, according to a Monday filing with the Singapore Exchange.
Currently, the company has a 52.6% stake in Aoxin, with the latest subscription see as a strategy to increase Aoxin's working capital as it looks to expand its dental business in China.
Currently, the company has a 52.6% stake in Aoxin, with the latest subscription see as a strategy to increase Aoxin's working capital as it looks to expand its dental business in China.
It won' t drifts too much as too many shares need to buy back.
Newbie85 ( Date: 01-Oct-2025 22:10) Posted:
|
What a bullish reversal signal. 
Looks like resuming the uptrend for Q& M. 
Looks like have to load some! 
Looks like resuming the uptrend for Q& M. 
Looks like have to load some! 
Q & M Dental Group (Singapore)
Between Aug 18 and 19, Quan Min Holdings acquired 5,641,800 shares in Q & M Dental Group (Singapore), an average price at S$0.445 a share. This increased the total interest of non-independent executive director and group chief executive officer Ng Chin Siau from 56.01 to 56.60 per cent. 
 
On Aug 20, Quan Min Holdings disposed of 20 million shares in a private off-market transaction to Lion Global Investors for a total consideration of S$9 million (excluding brokerage and stamp duties). This reduced Dr Ng&rsquo s total interest to 54.49 per cent.
 
On Aug 14, the group posted revenue of S$88.4 million for H1 FY2025, with core profit up 5 per cent to S$8.3 million. It also raised S$130 million from a S$500 million Multicurrency Debt Issuance Programme primarily for organic expansion and potential M& A. 
 
Ng highlighted that despite economic headwinds in H1 FY2025, the group&rsquo s core dental business stayed resilient through organic growth and strategic acquisitions. He also noted that the S$130 million in 3.95 per cent Notes reflected strong investor confidence and equipped the group with capital to drive its next growth phase. 
 
As at Jun 30, the group was operating 108 dental and five medical outlets, a dental college and a distribution company in Singapore. In Malaysia, it had 37 dental outlets and a distribution company, and in China, seven polyclinics, seven hospitals, a training centre, a distribution company and a dental lab.
 
SS bought 2.7534 mil from open market yesterday @ avg $0.4375
If based on the past records he will just continue to buy for days before pausing
If based on the past records he will just continue to buy for days before pausing
Limited shares in the market, don' t forget Co target 95 million share buyback 
Director started buying again good sign it will hit 50 cents soon
This is a strong one after weeks of consolidation....$0.44 up $0.01
SmallSmall ( Date: 07-Aug-2025 13:15) Posted:
|
Q& M Dental H1 profit tumbles 60% to S$3.9 million
It declares an interim cash dividend of S$0.004 per share for the period, unchanged from the year before
 
[SINGAPORE] Q& M Dental&rsquo s net profit fell 60 per cent to S$3.9 million for its first half ended Jun 30, 2025, from S$9.7 million in the year-ago period.  
 
This translated to an earnings per share of S$0.0041, compared with S$0.0102 in H1 2024. 
 
Ng Chin Siau, group chief executive of Q& M Dental, noted that the company faced &ldquo significant challenges&rdquo due to economic headwinds in H1 2025.    
 
Revenue for the six months stood at S$88.4 million, compared with S$88.8 million in the year-ago period. This came amid lower revenue for its other businesses segment, although revenue for its core dental business rose. 
 
The revenue contribution for the other businesses segment fell 74 per cent on the year to S$1.2 million from S$4.6 million, mainly due to the cessation of the group&rsquo s medical laboratory in September 2024 as its licence expired. 
 
Its core dental business&rsquo revenue grew 4 per cent year on year to S$87.2 million, from S$84.2 million. 
 
The improvements were due to the consolidation of Aoxin Q& M from an associate to a subsidiary in the six months, as well as higher contributions from its equipment and supplies distribution companies in Singapore and Malaysia. However, they were offset by marginally lower contributions from the group&rsquo s Singapore dental clinics. 
 
For the period, Q& M Dental recorded S$4.4 million of net other losses, due to the deemed disposal of Aoxin Q& M and EM2AI, when the company gained control of these entities and reclassified them from equity-accounted associates to subsidiaries in H1 2025. 
 
The group declared an interim cash dividend of S$0.004 per ordinary share for the period, unchanged from the prior corresponding period. The dividend will be paid on Sep 4 after book closure on Aug 22. 
The group said that it is exploring opportunities to expand its dental business beyond Singapore, particularly in the Johor-Singapore Special Economic Zone with the upcoming Rapid Transit System (RTS). 
 
&ldquo The company is considering various strategies to mitigate the potential outflow of patients to Johor, who may seek to capitalise on the financial advantages of the currency exchange rate once the RTS becomes operational around December 2026,&rdquo Q& M Dental said. 
01:13 AM EDT, 08/14/2025 (MT Newswires) -- Q & M Dental's (SGX:QC7) attributable profit dropped 60% during the first half of the year to SG$3.9 million from SG$9.7 million a year earlier, according to a Thursday filing with the Singapore Exchange.
Earnings per share fell to SG$0.0087 from SG$0.0083 in the comparable period.
Revenue was largely unchanged at SG$88.4 million from SG$88.8 million a year earlier.
The company declared an interim dividend of SG$0.004 per share for the period, unchanged from a year earlier.
Earnings per share fell to SG$0.0087 from SG$0.0083 in the comparable period.
Revenue was largely unchanged at SG$88.4 million from SG$88.8 million a year earlier.
The company declared an interim dividend of SG$0.004 per share for the period, unchanged from a year earlier.
Insiders restart their buying?
Volume and price movement detected
Volume and price movement detected
Aoxin Q& M Dental CEO resigns as whistle-blower report lodged
The company cites &lsquo differences in views and opinions&rsquo with parent Q& M Dental regarding the direction of the dental business as the reason for Dr Shao Yongxin leaving
 
[SINGAPORE] Catalist-listed Aoxin Q& M Dental announced the resignation of its executive director and CEO Shao Yongxin in a bourse filing on Tuesday (Jul 22).
 
This comes after the company&rsquo s audit committee (AC) received a whistle-blower report against Dr Shao on Monday. The committee has launched an investigation into the matter, it said.
 
&ldquo The board, on the recommendation of the AC, will update shareholders as soon as (the) investigation is complete,&rdquo said Aoxin.
 
Aoxin cited &ldquo differences in views and opinions&rdquo with its parent, mainboard-listed Q& M Dental, regarding the strategic direction of the dental business as the reason for Dr Shao&rsquo s resignation.
 
Aoxin&rsquo s general manager Dr Bai Yi and deputy general manager Huang Zhenxing will subsume the role and scope of the CEO.
 
Dr Shao held his positions since 2017, and will now work together with his successors to hand over his duties.
 
The Chinese spin-off of Singapore&rsquo s Q& M Dental Group had requested a trading halt on Tuesday morning, pending the release of an announcement. Aoxin operates dental hospitals and polyclinics in four different cities in Liaoning province in Northern China. It also distributes dental equipment and supplies.
 
Q& M Dental had issued a letter of demand to Dr Shao in April for about 72.3 million yuan (S$12.9 million). It had cited an October 2016 circular, where it said Dr Shao &ldquo had provided certain profit guarantees&rdquo in relation to an acquisition made by its subsidiary. This followed Shanghai Q& M Investment Management & Consulting&rsquo s acquisition of Shenyang Xinao Hospital Management from Dr Shao.
 
In May, Q& M Dental had made a mandatory unconditional cash offer for all the shares in Aoxin Q& M it did not already own.
Q& M Dental launches inaugural $130 mil notes prices at 3.95% due 2028
 
Q& M Dental Group has launched its inaugural offering of its multicurrency debt issuance programme at a price of 3.95% due 2028 for $130 million notes.
 
The series 001 notes were established on Dec 5, 2017, and are expected to be issued on July 10, 2025. The notes will be issued in registered form at an issue price of 100% of its principal amount and in denominations of $250,000.
 
The notes will bear interest at a fixed rate of 3.95% per annum, payable semi-annually on Jan 10 and July 10 in each year starting 2026.
 
Q& M Dental says that net proceeds will be used for general corporate purposes, including financing acquisitions and/or investments (including investments in associated companies), business expansions, refinancing of borrowings and financing of working capital and capital expenditure requirements of the group and/or its subsidiaries.
 
Q& M says that certain directors and or controlling shareholders of the company, and persons related to them, have been allocated about 2.88% of the $130 million in aggregate principal amount of notes that are to be issued.
7,041,300 shares were acquired by Quan Min Holdings at an average price of S$0.414 apiece and the share price pullback from $0.455 to $0.41 now! Buying might start to resume at this level!
Joelton ( Date: 30-Jun-2025 11:18) Posted:
|
Q& M Dental Group (Singapore)
Between Jun 23 and 26, Q& M non-independent executive director and group chief executive officer Ng Chin Siau increased his total interest from 55.03 per cent to 55.78 per cent. The 7,041,300 shares were acquired by Quan Min Holdings at an average price of S$0.414 apiece. At the end of April, Dr Ng&rsquo s total interest stood at 53.02 per cent.
 
Back in April, he maintained that the company is expanding both the number of dentists and number of clinics. Dr Ng added that its courses in its Dental College are now recognised by the Committee for Private Education under SkillsFuture Singapore, with a one-year EduTrust certification, and it aims to achieve the four-year award to attract more foreign dental students. 
 
Dr Ng also reiterated that having grown rapidly during Covid, Q& M Dental aims to pursue mergers and acquisitions over the next two to three years. At the same time, the company is leveraging its advanced AI-driven information and treatment services to attract strategic partnerships.
Based on my manual calculations, combining the SS and company share buybacks,
they have bought a total of 19.63 millions shares from the open market since 6 June 2025
they have bought a total of 19.63 millions shares from the open market since 6 June 2025
SmallSmall ( Date: 30-Jun-2025 09:09) Posted:
|
From today' s BT
 
Q& M Dental Group (Singapore)
Between Jun 23 and 26, Q& M non-independent executive director and group chief executive officer Ng Chin Siau increased his total interest from 55.03 per cent to 55.78 per cent. The 7,041,300 shares were acquired by Quan Min Holdings at an average price of S$0.414 apiece. At the end of April, Dr Ng' s total interest stood at 53.02 per cent.
Back in April, he maintained that the company is expanding both the number of dentists and number of clinics. Dr Ng added that its courses in its Dental College are now recognised by the Committee for Private Education under Skills-Future Singapore, with a one-year EduTrust certification, and it aims to achieve the four-year award to attract more foreign dental stu-dents.
Dr Ng also reiterated that having grown rapidly during Covid, Q& M
Dental aims to pursue mergers and acquisitions over the next two to three years. At the same time, the company is leveraging its advanced artificial information-driven information and treatment services to attract strategic part-nerships.
 
Q& M Dental Group (Singapore)
Between Jun 23 and 26, Q& M non-independent executive director and group chief executive officer Ng Chin Siau increased his total interest from 55.03 per cent to 55.78 per cent. The 7,041,300 shares were acquired by Quan Min Holdings at an average price of S$0.414 apiece. At the end of April, Dr Ng' s total interest stood at 53.02 per cent.
Back in April, he maintained that the company is expanding both the number of dentists and number of clinics. Dr Ng added that its courses in its Dental College are now recognised by the Committee for Private Education under Skills-Future Singapore, with a one-year EduTrust certification, and it aims to achieve the four-year award to attract more foreign dental stu-dents.
Dr Ng also reiterated that having grown rapidly during Covid, Q& M
Dental aims to pursue mergers and acquisitions over the next two to three years. At the same time, the company is leveraging its advanced artificial information-driven information and treatment services to attract strategic part-nerships.